0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Anti-RSV Antibody(AM14) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38P13614
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Anti RSV Antibody AM14 Market Research Report 2023
BUY CHAPTERS

Global Recombinant Human Anti-RSV Antibody(AM14) Market Research Report 2025

Code: QYRE-Auto-38P13614
Report
May 2025
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Human Anti-RSV Antibody(AM14) Market Size

The global market for Recombinant Human Anti-RSV Antibody(AM14) was valued at US$ 34.8 million in the year 2024 and is projected to reach a revised size of US$ 64.3 million by 2031, growing at a CAGR of 9.3% during the forecast period.

Recombinant Human Anti-RSV Antibody(AM14) Market

Recombinant Human Anti-RSV Antibody(AM14) Market

North American market for Recombinant Human Anti-RSV Antibody(AM14) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Human Anti-RSV Antibody(AM14) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Human Anti-RSV Antibody(AM14) include Creative Biolabs, Cambridge Biologics, Leading Biology, Biovision, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Anti-RSV Antibody(AM14), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Anti-RSV Antibody(AM14).
The Recombinant Human Anti-RSV Antibody(AM14) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Anti-RSV Antibody(AM14) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Anti-RSV Antibody(AM14) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Human Anti-RSV Antibody(AM14) Market Report

Report Metric Details
Report Name Recombinant Human Anti-RSV Antibody(AM14) Market
Accounted market size in year US$ 34.8 million
Forecasted market size in 2031 US$ 64.3 million
CAGR 9.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • >90%
  • >95%
  • >98%
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Creative Biolabs, Cambridge Biologics, Leading Biology, Biovision
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Anti-RSV Antibody(AM14) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Anti-RSV Antibody(AM14) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Recombinant Human Anti-RSV Antibody(AM14) Market growing?

Ans: The Recombinant Human Anti-RSV Antibody(AM14) Market witnessing a CAGR of 9.3% during the forecast period 2025-2031.

What is the Recombinant Human Anti-RSV Antibody(AM14) Market size in 2031?

Ans: The Recombinant Human Anti-RSV Antibody(AM14) Market size in 2031 will be US$ 64.3 million.

Who are the main players in the Recombinant Human Anti-RSV Antibody(AM14) Market report?

Ans: The main players in the Recombinant Human Anti-RSV Antibody(AM14) Market are Creative Biolabs, Cambridge Biologics, Leading Biology, Biovision

What are the Application segmentation covered in the Recombinant Human Anti-RSV Antibody(AM14) Market report?

Ans: The Applications covered in the Recombinant Human Anti-RSV Antibody(AM14) Market report are ELISA, WB, Others

What are the Type segmentation covered in the Recombinant Human Anti-RSV Antibody(AM14) Market report?

Ans: The Types covered in the Recombinant Human Anti-RSV Antibody(AM14) Market report are >90%, >95%, >98%, Others

Recommended Reports

Recombinant Protein Markets

Antibody-Based Therapeutics

RSV and Respiratory Markets

1 Recombinant Human Anti-RSV Antibody(AM14) Market Overview
1.1 Product Definition
1.2 Recombinant Human Anti-RSV Antibody(AM14) by Type
1.2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Market Value Comparison by Type (2024 VS 2031)
1.2.2 >90%
1.2.3 >95%
1.2.4 >98%
1.2.5 Others
1.3 Recombinant Human Anti-RSV Antibody(AM14) by Application
1.3.1 Global Recombinant Human Anti-RSV Antibody(AM14) Market Value by Application (2024 VS 2031)
1.3.2 ELISA
1.3.3 WB
1.3.4 Others
1.4 Global Recombinant Human Anti-RSV Antibody(AM14) Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue 2020-2031
1.4.2 Global Recombinant Human Anti-RSV Antibody(AM14) Sales 2020-2031
1.4.3 Global Recombinant Human Anti-RSV Antibody(AM14) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Human Anti-RSV Antibody(AM14) Market Competition by Manufacturers
2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Human Anti-RSV Antibody(AM14) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Human Anti-RSV Antibody(AM14), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Product Type & Application
2.7 Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Date of Enter into This Industry
2.8 Global Recombinant Human Anti-RSV Antibody(AM14) Market Competitive Situation and Trends
2.8.1 Global Recombinant Human Anti-RSV Antibody(AM14) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Human Anti-RSV Antibody(AM14) Players Market Share by Revenue
2.8.3 Global Recombinant Human Anti-RSV Antibody(AM14) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Human Anti-RSV Antibody(AM14) Market Scenario by Region
3.1 Global Recombinant Human Anti-RSV Antibody(AM14) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region: 2020-2031
3.2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region: 2020-2025
3.2.2 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region: 2026-2031
3.3 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region: 2020-2031
3.3.1 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region: 2020-2025
3.3.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region: 2026-2031
3.4 North America Recombinant Human Anti-RSV Antibody(AM14) Market Facts & Figures by Country
3.4.1 North America Recombinant Human Anti-RSV Antibody(AM14) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2031)
3.4.3 North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Anti-RSV Antibody(AM14) Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Anti-RSV Antibody(AM14) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2031)
3.5.3 Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Human Anti-RSV Antibody(AM14) Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Anti-RSV Antibody(AM14) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2020-2031)
4.1.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2020-2025)
4.1.2 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Type (2026-2031)
4.1.3 Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Type (2020-2031)
4.2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Type (2020-2025)
4.2.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Type (2026-2031)
4.2.3 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Human Anti-RSV Antibody(AM14) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2020-2031)
5.1.1 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2020-2025)
5.1.2 Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Application (2026-2031)
5.1.3 Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Application (2020-2031)
5.2.1 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Application (2020-2025)
5.2.2 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Application (2026-2031)
5.2.3 Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Human Anti-RSV Antibody(AM14) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Creative Biolabs
6.1.1 Creative Biolabs Company Information
6.1.2 Creative Biolabs Description and Business Overview
6.1.3 Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Product Portfolio
6.1.5 Creative Biolabs Recent Developments/Updates
6.2 Cambridge Biologics
6.2.1 Cambridge Biologics Company Information
6.2.2 Cambridge Biologics Description and Business Overview
6.2.3 Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Product Portfolio
6.2.5 Cambridge Biologics Recent Developments/Updates
6.3 Leading Biology
6.3.1 Leading Biology Company Information
6.3.2 Leading Biology Description and Business Overview
6.3.3 Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Product Portfolio
6.3.5 Leading Biology Recent Developments/Updates
6.4 Biovision
6.4.1 Biovision Company Information
6.4.2 Biovision Description and Business Overview
6.4.3 Biovision Recombinant Human Anti-RSV Antibody(AM14) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biovision Recombinant Human Anti-RSV Antibody(AM14) Product Portfolio
6.4.5 Biovision Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Anti-RSV Antibody(AM14) Industry Chain Analysis
7.2 Recombinant Human Anti-RSV Antibody(AM14) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Anti-RSV Antibody(AM14) Production Mode & Process Analysis
7.4 Recombinant Human Anti-RSV Antibody(AM14) Sales and Marketing
7.4.1 Recombinant Human Anti-RSV Antibody(AM14) Sales Channels
7.4.2 Recombinant Human Anti-RSV Antibody(AM14) Distributors
7.5 Recombinant Human Anti-RSV Antibody(AM14) Customer Analysis
8 Recombinant Human Anti-RSV Antibody(AM14) Market Dynamics
8.1 Recombinant Human Anti-RSV Antibody(AM14) Industry Trends
8.2 Recombinant Human Anti-RSV Antibody(AM14) Market Drivers
8.3 Recombinant Human Anti-RSV Antibody(AM14) Market Challenges
8.4 Recombinant Human Anti-RSV Antibody(AM14) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Anti-RSV Antibody(AM14) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Anti-RSV Antibody(AM14) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Anti-RSV Antibody(AM14), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Anti-RSV Antibody(AM14), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Anti-RSV Antibody(AM14) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Anti-RSV Antibody(AM14) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Anti-RSV Antibody(AM14) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Application (2026-2031)
 Table 70. Creative Biolabs Company Information
 Table 71. Creative Biolabs Description and Business Overview
 Table 72. Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Creative Biolabs Recombinant Human Anti-RSV Antibody(AM14) Product
 Table 74. Creative Biolabs Recent Developments/Updates
 Table 75. Cambridge Biologics Company Information
 Table 76. Cambridge Biologics Description and Business Overview
 Table 77. Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cambridge Biologics Recombinant Human Anti-RSV Antibody(AM14) Product
 Table 79. Cambridge Biologics Recent Developments/Updates
 Table 80. Leading Biology Company Information
 Table 81. Leading Biology Description and Business Overview
 Table 82. Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Leading Biology Recombinant Human Anti-RSV Antibody(AM14) Product
 Table 84. Leading Biology Recent Developments/Updates
 Table 85. Biovision Company Information
 Table 86. Biovision Description and Business Overview
 Table 87. Biovision Recombinant Human Anti-RSV Antibody(AM14) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Biovision Recombinant Human Anti-RSV Antibody(AM14) Product
 Table 89. Biovision Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Recombinant Human Anti-RSV Antibody(AM14) Distributors List
 Table 93. Recombinant Human Anti-RSV Antibody(AM14) Customers List
 Table 94. Recombinant Human Anti-RSV Antibody(AM14) Market Trends
 Table 95. Recombinant Human Anti-RSV Antibody(AM14) Market Drivers
 Table 96. Recombinant Human Anti-RSV Antibody(AM14) Market Challenges
 Table 97. Recombinant Human Anti-RSV Antibody(AM14) Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Anti-RSV Antibody(AM14)
 Figure 2. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Anti-RSV Antibody(AM14) Market Share by Type: 2024 & 2031
 Figure 4. >90% Product Picture
 Figure 5. >95% Product Picture
 Figure 6. >98% Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Recombinant Human Anti-RSV Antibody(AM14) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Human Anti-RSV Antibody(AM14) Market Share by Application: 2024 & 2031
 Figure 10. ELISA
 Figure 11. WB
 Figure 12. Others
 Figure 13. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant Human Anti-RSV Antibody(AM14) Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Recombinant Human Anti-RSV Antibody(AM14) Sales (2020-2031) & (K Units)
 Figure 16. Global Recombinant Human Anti-RSV Antibody(AM14) Average Price (US$/Unit) & (2020-2031)
 Figure 17. Recombinant Human Anti-RSV Antibody(AM14) Report Years Considered
 Figure 18. Recombinant Human Anti-RSV Antibody(AM14) Sales Share by Manufacturers in 2024
 Figure 19. Global Recombinant Human Anti-RSV Antibody(AM14) Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Recombinant Human Anti-RSV Antibody(AM14) Players: Market Share by Revenue in Recombinant Human Anti-RSV Antibody(AM14) in 2024
 Figure 21. Recombinant Human Anti-RSV Antibody(AM14) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Recombinant Human Anti-RSV Antibody(AM14) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
 Figure 24. North America Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
 Figure 25. United States Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
 Figure 28. Europe Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Region (2020-2031)
 Figure 36. China Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Human Anti-RSV Antibody(AM14) Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Recombinant Human Anti-RSV Antibody(AM14) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Type (2020-2031)
 Figure 55. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Recombinant Human Anti-RSV Antibody(AM14) by Application (2020-2031)
 Figure 58. Global Recombinant Human Anti-RSV Antibody(AM14) Price (US$/Unit) by Application (2020-2031)
 Figure 59. Recombinant Human Anti-RSV Antibody(AM14) Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart